Bienvenido a Med Info Alert, el servicio de literatura científica de Boehringer Ingelheim que te permite estar al día de las publicaciones más recientes y relevantes sobre la enfermedad pulmonar intersticial difusa (EPID).
Si estás interesado en recibir alguna publicación de este mes, a continuación, puedes descargarla o acceder a tu cuenta para solicitarla.
¿También quieres estar actualizado los próximos meses con las publicaciones más recientes sobre EPID? Regístrate en avances en fibrosis pulmonar.
Patel AS, Miller E, Regis SM, Hunninghake GM, Price LL, Gawlik M, McKee AB. Et al. Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis. Respir Res. 2023
Khanna D, Maher TM, Volkmann ER, Allanore Y, Smith V, Assassi S, Kreuter M. et al. Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression. RMD Open. 2023
Huang Y, Guzy R, Ma SF, Bonham CA, Jou J, Schulte JJ, Kim JS. et al. Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2023
Feng X, Duan Y, Lv X, Li Q, Liang B, Ou X. The Impact of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE). J Clin Med. 2023
Raman L, Stewart I, Barratt SL, Chua F, Chaudhuri N, Crawshaw A, Gibbons M. et al. Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study. ERJ Open Research 2022
Deterding R, Young LR, DeBoer EM, Warburton D, Cunningham S, Schwerk N, Flaherty KR. et al. Nintedanib in children and adolescents with fibrosing interstitial lung diseases. Eur Respir J. 2023
Nakshbandi G, Moor CC, Antoniou K, Cottin V, Hoffmann-Vold AM, Koemans EA, Kreuter M. et al. Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE. BMC Pulm Med. 2023
Behr J, Bonella F, Günther A, Koschel D, Prasse A, Pittrow D, Klotsche J. et al; INSIGHTS-ILD Study Group. Investigating significant health trends in progressive fibrosing interstitial lung disease (INSIGHTS-ILD): rationale, aims and design of a nationwide prospective registry. BMC Pulm Med. 2023
Bruni C, Occhipinti M, Pienn M, Camiciottoli G, Bartolucci M, Bosello SL, Payer C. et al. Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease. Rheumatology (Oxford). 2023
Kim TH, Kim HJ, Song MJ, Kwon BS, Kim YW, Lim SY, Lee YJ. et al. Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia. Sci Rep. 2023
Shapanis A, Jones MG, Schofield J, Skipp P. Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis. Thorax. 2023
Cerro Chiang G, Parimon T. Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers. Int J Mol Sci. 2023
PC-ES-110340